Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Shares of National Instruments (NATI 16.93%) are soaring 17.1% at 10:29 a.m. ET after the instrumentation hardware and software products company announced it was undertaking a strategic review of its business, including the possible sale of the company.
National Instruments says it has been approached by several parties interested in buying the business.
Image source: Getty Images.
National Instruments’ stock has been trading in a fairly narrow range over the past five months as uncertainty about the global economy has kept a check on what otherwise seemed a solid, growing business. Wall Street analysts have been somewhat bullish about the instrumentation company’s prospects and had assigned a one-year price target of around $48 a share, or about 20% above where it closed yesterday before announcing the strategic review.
Noting that National Instruments has been transforming itself over the past few years into a leaner, more efficient operation, Board Chairman Michael McGrath said, “we believe initiating a strategic review to explore options to maximize value for our shareholders is the right path forward at this time.”
While National Instruments begins the review process, the board adopted a shareholder rights plan that will flood the market with stock and dilute any attempt by anyone trying to acquire more than 10% of its outstanding shares. The rights plan will expire in one year.
National Instruments says it’s not under any timetable to complete the review, and nothing might come out of it, either a business combination or an outright sale of the company.
Rich Duprey has no position in any of the stocks mentioned. The Motley Fool recommends National Instruments. The Motley Fool has a disclosure policy.
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services.
Making the world smarter, happier, and richer.
Market data powered by Xignite.
